Active Stock on Watch: Dods Group PLC (DODS.L)

Dods Group PLC (DODS.L) shares are moving today on volatility -50.00% or $-12.625 from the open. The LSE listed company saw a recent bid of 12.625 and 60000 shares have traded hands in the session.

Active investors are typically interested in the factors that drive stock price movements. Buying an individual stock means that you own a piece of the company. The hope is that the company does very well and becomes highly profitable. A profitable company may decide to do various things with the profits. They may reinvest profits back into the business, or they may choose to pay shareholders dividends from those earnings. Sometimes stocks may eventually become undervalued or overvalued. Spotting these trends may lead to further examination or the underlying fundamentals of the company. A company that continues to disappoint on the earnings front may have some issues that need to be addressed. It is highly important to make sure all the research is done on a stock, especially if the investor is heavily weighted on the name. Sometimes earnings reports may be good, but the stock price does not reflect that. Having a good understanding of the entire picture may help investors better travel the winding stock market road.

Now let’s take a look at how the fundamentals are stacking up for Hikma Pharmaceuticals PLC (HIK.L). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. Hikma Pharmaceuticals PLC currently has a yearly EPS of 66.20. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.

Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Hikma Pharmaceuticals PLC (HIK.L) currently has Return on Equity of 8.30. ROE is a ratio that measures profits generated from the investments received from shareholders. In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.

Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Hikma Pharmaceuticals PLC (HIK.L) has a current ROIC of 5.83. ROIC is calculated by dividing Net Income - Dividends by Total Capital Invested.

Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.

Turning to Return on Assets or ROA, Hikma Pharmaceuticals PLC (HIK.L) has a current ROA of 4.54. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets. A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.

Leave A Reply

Your email address will not be published.